A pilot study published in *Tobacco Control* on 10 November 2026 examined the effects of e-cigarette use on pulmonary function in 22 individuals who had vaped within the previous 30 days. Researchers measured lung function at the start of the study and again approximately one year later.
Dr Katie East, Associate Professor in Public Health at Brighton and Sussex Medical School, noted that the study was small-scale and lacked a control group. She also pointed out that participants could have smoked up to five combustible tobacco products in the past month, meaning possible confounding with other tobacco use cannot be ruled out. While forced expiratory volume reportedly declined as vaping frequency increased, this trend was not statistically significant.
Professor Lion Shahab, Professor of Health Psychology at University College London, also highlighted the absence of a comparison group of non-smokers and non-vapers, making it difficult to determine if observed changes were linked to vaping or would have occurred naturally. He added that the study's small group of volunteers makes it challenging to generalise the findings, and that no clear change was found in the FEV₁/FVC ratio, a key indicator for airflow obstruction in conditions like COPD.
Both experts agree that the findings are preliminary and that larger, more representative studies with appropriate control groups and longer follow-up periods are needed before reliable conclusions can be drawn about the impact of vaping on lung health.